03.2024
Our founder and partner, Robert L. Buchanan was sworn in for admission to the Bar of the Supreme Court of the United States on Friday, March 15, 2023.
Robert L. Buchanan was three months ago accepted for admission to the Bar og the Surpreme Court of the United States (SCOTUS) after being nominated by his alma mater, Suffolk University Law School, Boston. Friday, March 15 the swearing in ceremony and reception at SCOTUS went down.
03.2024
Friday, 15th March saw the final day of Ventac Partners' week-long “build a biotech” course at Norwegian University of Science and Technology (NTNU) in Trondheim, Norway, with some entertaining and successful elevator pitches to some tired and initially skeptical investors.
This was the 21st edition of the course since it started in 2004 and as usual the student teams did excellent work in converting our 10 technology cases - in the form of "invention disclosures", similar to those usually submitted to university technology transfer offices - into investable business cases. The business presentation session was remarkably impressive this year.
Thanks to all this year's BI3018 students for their rapid learning, excellent teamwork and refreshing enthusiasm!
Many thanks also to Prof. Berit Johansen for hosting and running the course with us and to our fellow lecturers and supervisors from NTNU TTO: Knut J. Egelie and Eivind Andersen, and from Dehns: Haakon Thue Lie and Axel Moulin
03.2023
Friday 24th March saw the last day of Ventac Partners week-long “build a biotech” course at NTNU, Trondheim, Norway with some entertaining and successful elevator pitches to some skeptical investors.
This was the biggest ever class since the course started in 2004 and we have to say the best in terms of the rapid understanding, development and credibility of the 10 teams developing the business cases given to them at the beginning of the week.
Working from only a few sheets of paper and a limited understanding of IP and the hurdles of the biotech and medtech industry at the start of the course, the business plan presentations we saw on day 4 were particularly impressive.
The future looks bright for the next generation of entrepreneurs.
03.2023
Today marks the start of the 20th edition of Ventac Partners’ “build a biotech” course at NTNU, now in its 19th year. Over 80 Master’s & PhD students will spend the week learning about IP strategy and product development, and work in groups to turn 10 technology cases into investable businesses.
We are joined on the course by representatives of NTNU Technology Transfer AS, the Center for Intellectual Property (CIP) (established by Chalmers University of Technology, University of Gothenburg, and NTNU), Aarhus University Forskning - Technology Transfer Office and the Norwegian Industrial Property Office.
